Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States

Neurology

Volumn 83, Issue 20, 2014, Pages 1823-1830

  Duffy, Jonathan ^a   Weintraub, Eric ^a   Vellozzi, Claudia ^a   Destefano, Frank ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ARTICLE; CATAPLEXY; CHILD; COHORT ANALYSIS; DAYTIME SOMNOLENCE; DRUG SAFETY; FEMALE; GROUPS BY AGE; HUMAN; ICD-9; ICSD-2; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NARCOLEPSY; ONSET AGE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SEASONAL VARIATION; UNITED STATES; VACCINATION; VIRUS STRAIN; HEALTH CARE PLANNING; IMMUNOLOGY; INFLUENZA, HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; NARCOLEPSY; UNITED STATES; YOUNG ADULT;

EID: 84925286899     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000987     Document Type: Article

References (30)

1. Ahmed I, Thorpy M. Clinical features, diagnosis and treatment of narcolepsy. Clin Chest Med 2010;31:371-381.
2. Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G. The epidemiology of narcolepsy. Sleep 2007;30: 13-26.
3. Morrish E, King MA, Smith IE, Shneerson JM. Factors associated with a delay in the diagnosis of narcolepsy. Sleep Med 2004;5:37-41.
4. The MPA investigates reports of narcolepsy in patients vaccinated with Pandemrix [online]. Available at: Http://www.lakemedelsverket.se/english/All-news/NYHETER-2010/The-MPA-investigates-reports-of-narcolepsy-in-patientsvaccinated-with-Pandemrix/. Accessed July 15, 2014.
5. National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations [online]. Available at: Http://www4.thl.fi/en-US/web/en/pressrelease?id522930 Accessed July 15, 2014.
6. Statement on narcolepsy and vaccination [online]. Available at: Http://www.who.int/vaccine-safety/committee/topics/influenza/pandemic/h1n1-safety-assessing/narcolepsy-statement/en/Accessed July 15, 2014.
7. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012;7:e33536.
8. CDC statement on narcolepsy following Pandemrix influenza vaccination in Europe [online]. Available at: Http://www.cdc.gov/vaccinesafety/Concerns/h1n1-narcolepsy-pandemrix.html. Accessed July 15, 2014.
9. Baggs J, Gee J, Lewis E, et al. The Vaccine Safety Datalink: A model for monitoring immunization safety. Pediatrics 2011;127(suppl 1):S45-S53.
10. Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia: An update based on the International Classification of Sleep Disorders, 2nd edition. Sleep Med Rev 2007;11:377-388.
11. Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: A population-based study. Sleep 2002;25:197-202.
12. Miller E, Andrews N, Stellitano L, et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 2013;346:f794.
13. O'Flanagan D, Barret AS, Foley M, et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009- December 2010. Euro Surveill 2014;19:15-25.
14. Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: A population- And registry-based cohort study with over 2 years of follow-up. J Intern Med 2014;275: 172-190.
15. Heier MS, Gautvik KM, Wannag E, et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013; 14:867-871.
16. Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013;136:2486-2496.
17. Narcolepsy in Association with Pandemic Influenza Vaccination (A Multi-Country European Epidemiological Investigation). Stockholm: European Centre for Disease Prevention and Control; 2012.
18. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012;7:e33723.
19. Increased risk of narcolepsy observed also among adults vaccinated with Pandemrix in Finland [online]. Available at: Http://www4.thl.fi/en-US/web/en/pressrelease?id533516. Accessed July 15, 2014.
20. Garcon N, Vaughn DW, Didierlaurent AM. Development and evaluation of AS03, an adjuvant system containing alpha-tocopherol and squalene in an oil-in-water emulsion. Expert Rev Vaccines 2012;11:349-366.
21. Black JL III. Narcolepsy: A review of evidence for autoimmune diathesis. Int Rev Psychiatry 2005;17:461-469.
22. The Allele Frequency Net Database [online]. Available at: Http://allelefrequencies.net/. Accessed July 15, 2014.
23. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007;68:779-788.
24. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001;68: 686-699.
25. Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: The role of H1N1 infection and vaccination. Lancet Neurol 2014;13: 600-613.
26. Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011;70:410-417.
27. Choe YJ, Bae GR, Lee DH. No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: An ecological study. Vaccine 2012;30:7439-7442.
28. Wijnans L, Lecomte C, de Vries C, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-1254.
29. Lee GM, Greene SK, Weintraub ES, et al. H1N1 and seasonal influenza vaccine safety in the Vaccine Safety Datalink Project. Am J Prev Med 2011;41:121-128.
30. Ahmed SS, Schur PH, MacDonald NE, Steinman L. Narcolepsy, 2009 A (H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014;50:1-11.